期刊文献+

myc拮抗基因Mad1、Mxi1和Rox在白血病细胞中的表达和突变 被引量:2

Expression and mutation of myc antagonist genes Madl, Mxil and Rox in leukemia cells
原文传递
导出
摘要 目的分析 Mad1、Mxi1和 Rox 基因突变在白血病发病中的作用。方法利用逆转录-聚合酶链反应(RT-PCR)、单链构象多态性(SSCP)分析及 DNA 序列分析技术检测了26例初治急性白血病(AL)患者、30名健康对照者和7种白血病细胞株中 Mad1、Mxi1和 Rox 基因表达及突变情况。结果 RT-PCR 检测结果显示所有标本中均可检测到 Mad1、Mxi1和 Rox 基因的表达;SSCP 分析结果显示所有标本中有4个位点发生多态性改变:Mad1中12个位点,Mxi1和 Rox 中各1个位点。DNA 序列分析显示所有标本中有9个位点发生错义突变:Mad1中2个位点均发现于初治 AL 患者;Mxi1中4个位点,其中3个位点发现于初治 AL 患者,1个位点发现于 KG1细胞株;Rox 中3个位点均发现于初治AL 患者。26例初治 AL 患者 Mad1、Mxi1和 Rox 基因的突变发生分别为2例、3例和3例。结论首次在 AL 患者细胞中发现 Mad1、Mxi1和 Rox 基因突变,提示 Mad1、Mxi1和 Rox 基因的突变可能与白血病的发病有关。 Objective To investigate the expression and mutation of Madl, Mxil and Rox genes in leukemia cells. Methods Expression and mutation of Madl, Mxil and Rox genes in bone marrow mononu- clear cells (BMMNC) from 26 de novo acute leukemia (AL) patients, and in peripheral blood mononuclear cells (PBMNC) from 30 healthy volunteers, as well as in 7 human leukemic cell lines were analyzed by re- verse transcription-polymerase chain reaction ( RT-PCR), single strand conformational polymorphism (SSCP) and DNA sequencing. Results RT-PCR showed that all the above cells expressed Madl, Mxil and Rox mRNA. SSCP revealed four polymorphisms: two in Madl, one each in Mxil and Rox. DNA sequencing de- tected nine missense mutations: two in Madl in AL patients, four in Mxil (three in AL patients and one in KG-1 cell line), and three in Rox in AL patients. The mutations of Madl, Mxil and Rox mRNA were detec- ted in 2, 3 and 3 patients, respectively. Conclusion It is for the first time to demonstrate the mutations of Madl, Mxil and Rox genes in AL patients suggesting these mutated genes involve in the pathogenesis of leu- kemia.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第11期745-749,共5页 Chinese Journal of Hematology
关键词 基因 肿瘤抑制 基因 Madl 基因 Mxil 基因 ROX 白血病 基因转变 Gene, tumor suppressor Gene, Madl Gene, Mxil Gene, Rox Leukemia Gene conversion
  • 相关文献

参考文献9

  • 1Chen J, Willingham T, Margraf LR, et al. Effects of the myc oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat Med, 1995,1:638- 643.
  • 2Hermans KG, van Alewijk DC, Veltman JA, et al. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines. Genes Chromosomes Cancer, 2004, 39:171-184.
  • 3Takahashi T, Konishi H, Kozaki K, et al. Molecular analysis of a myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers. Jpn J Cancer Res, 1998, 89: 347-351.
  • 4Han S, Park K, Kim HY, et al. Clinical implication of altered expression of Mad1 protein in human breast carcinoma. Cancer, 2000, 88 : 1623-1632.
  • 5Ohta Y, Hamada Y, Saitoh N, et al. Effect of the transcriptional repressor Mad1 on proliferation of human melanoma cells. Exp Dermatol, 2002, 11:439-447.
  • 6Cvekl A Jr, Zavadil J, Birshtein BK, et al. Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene. Eur J Cancer, 2004, 40:2525-2532.
  • 7Ariyanayagam-Baksh SM, Baksh FK, Swalsky PA, et al. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma. Mod Pathol, 2003, 16:992-995.
  • 8Raja S, Finkelstein SD, Baksh FK, et al. Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett' s esophagus. Ann Thorac Surg, 2001, 72:1130-1135.
  • 9Schreiber-Agus N, Meng Y, Hoang T, et al. Role of Mxil in ageing organ systems and the regulation of normal and neoplastic growth. Nature, 1998, 393:483-487.

同被引文献13

  • 1王逸群,朱平,石永进,顾江英,卜定方,刘辉,张英.遗传性铁粒幼细胞贫血致病的ALAS2基因表达载体的构建[J].中国实验血液学杂志,2004,12(5):687-693. 被引量:2
  • 2Hurlin P J, Huang J. The MAX-interacting transcription factor network[ J ]. Semin Cancer Biol, 2006,16 ( 4 ) : 265 -274.
  • 3Gallant P. Myc/Max/Mad in invertebrates: the evolution of the Max network [ J ]. Cult Top Microbiol Immunol, 2006, 302:235-253.
  • 4Manni I, Tunici P, Cirenei N, et al. Mxil inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression[ J]. Br J Cancer, 2002, 86 (3) :477-484.
  • 5Wong W J, Simon M C. The role of MXI1 in VHL defi- cient tumorigenesis [ J ]. Cancer Biol Ther, 2008, 7 ( 10 ) : 1628-1629.
  • 6Delpuech O, Griffiths B, East D, et al. Induction of Mxi1-SR by FOXO3a contributes to repression of Myc-de- pendent gene expression[ J ]. Mol Cell Biol, 2007, 27 (13) :4917-4930.
  • 7郭晓玲,潘岐,张学军,等.Expression and mutation anal-ysis of genes that encode the Myc antagonists Madl, Mxil and Rox in acute leukaemia[J]. Leuk Lymphoma, 2007,48(6) : 1200-1207.
  • 8Zada AA, Pulikkan J A, Bararia D,et al. Proteomie discovery of Max as a novel interacting partner of C/EBP:a Myc/Ma.z:/Mad link. Leukemia,2006 ;20(12) :2137-2146.
  • 9Gallant P. Myc/Max/Mad in invertebrates:the evolution of the Max network. Curr Top Microbiol Immunol, 2006; 302: 235- 253.
  • 10Manni I, Tunici P, Cirenei N, et al. Mxil inhibits the proliferation of U87 glioma cells through down regulation of eyelin B1 gene expression. Brit J Cancer,2002;86(3):477-484.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部